About Vanguards of Health Care by Bloomberg Intelligence
Vanguards of Healthcare is a series of exclusive conversations with management teams and thought leaders discussing changes on the forefront of the industry, including innovations in medical products and technologies, advances in clinical research, new service models, wellness and regulations.
Tandem Diabetes’ Pump Portfolio Has Rubber Hitting the Floor
“If you look at the tubeless market, you know, we're seeing growth rates in excess of 25% annually,” Tandem Diabetes CEO John Sheridan explains to Bloomberg Intelligence about the growth opportunities in insulin pumps. In this episode of Vanguards of Health Care, Sheridan sits down with BI analyst Matt Henriksson for an in-depth interview about Tandem’s pending launch of Mobi Tubless, an insulin pump designed to wear on the body for discretion and the AI-powered Control-IQ Plus algorithm for simplicity. The conversation also touches on the company’s pay-as-you-go business model and future product development, including the next generation Mobi pumps utilizing Sigi technology from its AMF acquisition and a new closed loop algorithm.
See omnystudio.com/listener (https://omnystudio.com/listener) for privacy information.
8 Oct 2026
Cityblock Health Reimagines Care for Those Left Behind
“It’s not about the technology itself, it’s about the form factor,” says Dr. Toyin Ajayi, co-founder and CEO of Cityblock Health. She joins Bloomberg Intelligence analyst Jonathan Palmer to explain how the company is redesigning care for complex Medicaid and Medicare populations around medical, behavioral and social needs. Ajayi details Cityblock’s value-based model, which rewards better outcomes and lower costs, and explains how AI is increasingly shaping care. One surprising finding: seniors and Medicaid members are willing to engage with technology when it comes through familiar channels like voice and text. The conversation also explores Cityblock’s use of real-world data to guide next-best actions and its ambition to expand nationally.
See omnystudio.com/listener (https://omnystudio.com/listener) for privacy information.
1 Oct 2026
Natera’s Billion-Dollar R&D Bet on the Future of Cancer Testing
“Clinical data is the key to being successful in diagnostics,” Steve Chapman, CEO of Natera, tells Bloomberg Intelligence analyst Jonathan Palmer as he explains how an early bet on evidence helped turn a small genetic-testing company into a broad diagnostics platform. Chapman traces Signatera from a side project into a leading minimal residual disease (MRD) test and details Natera’s nearly $1 billion R&D investment to push into genome-based testing, early cancer detection and new indications. The conversation also explores the next layer of value from Natera’s platform — millions of longitudinal data points, AI-enhanced test results and patient experiences, more efficient biopharma trials and the potential to use neoantigen prediction algorithms to support personalized cancer vaccines.
See omnystudio.com/listener (https://omnystudio.com/listener) for privacy information.
Who has been a guest on Vanguards of Health Care by Bloomberg Intelligence
Names identified in recent episode analyses. Showing up to five guests.
Mick Farrell
Kyle Armbrester
Ryan Rhodes
Ken Mobeck
Kevin Lobo
Reach and audience
Public platform figures. Ratings count people who left a rating, not total listeners.
YouTube views
419,108,275
Score snapshot 15 Sept 2025
Apple Podcasts (US)
5.0 / 5
6 ratings
Spotify
4.9 / 5
9 ratings
Podcast Authority Score: 80 / 100
A composite of feed quality, social presence, YouTube performance and engagement. Read the methodology.
Quality
96
Social presence
0
YouTube
93
Engagement
68
Contact Vanguards of Health Care by Bloomberg Intelligence
Guest appearances
Books guests
Based on episode analysis; this does not confirm that the show is currently accepting guests.
Pod Engine is an independent podcast discovery and analytics service and is not affiliated with or endorsed by this podcast. Artwork and show content belong to their owners. Full legal notice.
Explore this show Podcast research with Pod Engine
